Tumor Treating Fields for the Treatment of Brainstem Gliomas

Part of paid clinical trials in Atlanta, Georgia.

Sponsor
Emory University
Study ID
NCT05310448
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Optune device — DEVICE
    Wear Optune device

Study Details

This clinical trial tests the safety and side effects of tumor treating fields in treating patients with gliomas located in the brainstem. Optune is a wearable, portable, treatment that creates low-intensity, wave-like electric fields called tumor treating fields (TTFields), which interfere with cancer cell division. TTFields may prevent growth or decrease size of gliomas in patients

Key Dates

Start date
May 11, 2022
Status verified
Sep 2025
Primary completion
Sep 1, 2026
Completion
May 1, 2027

Study Design

Enrollment
10 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Treatment (tumor treating fields)
    After completion of standard of care radiation therapy, patients wear the Optune device for 18 hours per day for 12 months in the absence of disease progression or unacceptable toxicity.

Primary Outcome Measure

Incidence of adverse events [ Time Frame: Up to 12 months after TTFields started ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Emory Proton Therapy CenterAtlantaGeorgia30308
India Green
404-778-1738
Jim Zhong, MD (PRINCIPAL_INVESTIGATOR)
Emory Saint Joseph's HospitalAtlantaGeorgia30342
India Green
404-778-1738
Jim Zhong, MD (PRINCIPAL_INVESTIGATOR)
Emory University/Winship Cancer InstituteAtlantaGeorgia30322
India Green
404-778-1738
Jim Zhong, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Atlanta, GA

By condition

Related Studies